相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
Recombinant Human Tie2 / CD202b / TEK protein (Catalog#10700-H08H)
- 亚型:
Mouse IgG1
- 形态:
液体
- 保存条件:
-20℃ 至 -80℃
- 克隆性:
单克隆
- 标记物:
PE
- 适应物种:
Human
- 保质期:
12个月
- 抗原来源:
10700-H08H
- 目录编号:
10700-MM07-P
- 级别:
免疫学试剂
- 库存:
99
- 供应商:
北京义翘神州科技股份有限公司
- 宿主:
Mouse
- 应用范围:
FCM
- 浓度:
详见说明书
- 靶点:
TEK
- 抗体英文名:
Tie2 / CD202b / TEK Antibody (PE), Mouse MAb
- 抗体名:
Tie2 / CD202b / TEK Antibody (PE), Mouse MAb
- 规格:
25 Tests/100 Tests
| 规格: | 25 Tests | 产品价格: | ¥700 |
|---|---|---|---|
| 规格: | 100 Tests | 产品价格: | ¥2200 |
抗体种属:Human
抗体靶点:TEK
抗体应用:FCM
抗原货号:10700-H08H
抗原描述:Recombinant Human Tie2 / CD202b / TEK protein (Catalog#10700-H08H)
抗体宿主:Mouse
抗体Ig类型:Mouse IgG1
抗体纯化方法:Protein A
抗体标记:PE
抗体制备:This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human Tie2 / CD202b / TEK (rh Tie2 / CD202b / TEK; Catalog#10700-H08H; NP_000450.2; Met1-Lys745) and conjugated with PE under optimum conditions, the unreacted PE was removed.
抗体特异性:Human Tie2 / CD202b / TEK
抗体保存:This antibody can be stored at 2℃-8℃ for twelve months without detectable loss of activity. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during disposal.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验/v )封闭。 Fab 片段 抗体是用木瓜蛋白酶消化 IgG 后得到的。这些抗体只含有一个结合位点。它们用来封闭内源性的免疫球蛋白,或者在使用相同物种来源的一抗作多标记的实验中,用于封闭暴露的免疫球蛋白。而二价的抗体( whole IgG 或 F ( ab’ ) 2 片段)不能用来封闭,因为它们有二个结合位点。封闭后,一些结合位点可能为暴露出来,与一抗结合,从而导致高的背景或假阳性标记。 第二步: 在左边标记“ antibody description ”的拦里找到
k) AnnA1 in human tumour neovasculature We immuno-stained tissue sections of human solid tumours. AnnA1 antibody labelled blood vessels of human prostate, liver, breast and lung tumours but not matched normal tissues (Fig. 6). Antibodies to platelet
【翻译】单克隆抗体治疗肿瘤发展趋势Nature Reviews Drug Discovery 6, 349-356 (May 2007)
单抗讨论小组报名帖|\|/|单抗讨论小组日常讨论交流贴|\|/|\|/|单抗讨论小组工作交流与工资贴 此话题已收录于“单抗小组讨论话题集锦” By waynepionnet Development trends for monoclonal antibody cancer therapeutics 单克隆抗体治疗肿瘤发展趋势 Janice M. Reichert1 & Viia E. Valge-Archer2 Abstract 摘要
技术资料暂无技术资料 索取技术资料









